LSV Asset Management Sells 57,100 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

LSV Asset Management lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 96.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,400 shares of the company's stock after selling 57,100 shares during the period. LSV Asset Management's holdings in Henry Schein were worth $166,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Smartleaf Asset Management LLC raised its holdings in Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the period. CIBC Asset Management Inc grew its position in Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after acquiring an additional 169 shares in the last quarter. Metis Global Partners LLC grew its stake in Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock worth $291,000 after purchasing an additional 187 shares in the last quarter. Central Pacific Bank Trust Division lifted its stake in Henry Schein by 2.0% in the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock worth $706,000 after acquiring an additional 200 shares during the last quarter. Finally, Sanctuary Advisors LLC raised its position in shares of Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after acquiring an additional 203 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Trading Down 3.1 %

HSIC stock traded down $2.02 during midday trading on Monday, reaching $62.71. The company's stock had a trading volume of 114,795 shares, compared to its average volume of 1,611,041. The business's 50-day simple moving average is $70.41 and its 200-day simple moving average is $71.98. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market cap of $7.68 billion, a PE ratio of 25.85, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.66 earnings per share. As a group, sell-side analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Activity

In other news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on HSIC. StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and upped their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Barrington Research reissued an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. Finally, UBS Group lowered their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and an average price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.